Index Entries

1536 Results
TitleIS Publication Date
Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS VirusApril 20, 2012
Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individualsJune 23, 2021
Immunohistologic Features of Cerebral Venous Thrombosis Due to Vaccine-Induced Immune Thrombotic ThrombocytopeniaMay 26, 2023
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infectionJanuary 6, 2021
Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 InfectionMay 17, 2021
Impact of community masking on COVID-19:A cluster-randomized trial in BangladeshDecember 2, 2021
Impact of COVID-19 and lockdown on mental health of children and adolescents: A narrative review with recommendationsNovember 2020
Impact of COVID-19 on excess mortality, life expectancy, and years of life lost in the United StatesSeptember 1, 2021
Impact of Delta on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UKAugust 1, 2021
Impact of mRNA and Inactivated COVID-19 Vaccines on Ovarian ReserveMarch 24, 2025
Impact of obesity on intensive care outcomes in patients with COVID-19 in Sweden—A cohort studyOctober 13, 2021
Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individualsJuly 1, 2021
Impacts of COVID-19 on global poverty, food security, and diets: Insights from global model scenario analysisApril 8, 2021
Imperfect Vaccination Can Enhance the Transmission of Highly Virulent PathogensJuly 27, 2015
Improving communications around vaccine breakthrough and vaccine effectivenessJuly 29, 2021
In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus originJune 24, 2021
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)March 9, 2020
In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2October 31, 2020
Inadvertent Exposure to Pharmacologically Designed Lipid Nanoparticles Via Bodily Fluids: Biologic Plausibility and Potential ConsequencesFebruary 22, 2024
Incidence and management of the main serious adverse events reported after COVID-19 vaccinationJune 12, 2024
Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety DatalinkApril 26, 2022
Incidence of SARS-CoV-2 infection among previously infected or vaccinated employeesFebruary 9, 2022
Incomplete Subacute Transverse Myelitis Following Vaccination With Pfizer-BioNTech COVID-19 mRNA Vaccine: A Case ReportDecember 16, 2021
Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in JapanApril 8, 2024
Increased emergency cardiovascular events among under-40 population in Israel during vaccine rollout and third COVID-19 waveApril 28, 2022
Increased risk of fetal loss after COVID-19 vaccinationOctober 12, 2023
Independent report: JCVI statement on vaccination of children aged 5 to 11 years oldFebruary 16, 2022
Infection fatality rate of COVID-19 inferred from seroprevalence dataOctober 14, 2020
Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination?August 9, 2021
Inflammatory Arthritis Associated with COVID-19 VaccinationMarch 09, 2023
Influence of SARS-CoV-2 variants on COVID-19 epidemiological and clinical profiles: a comparative analysis of two waves of casesOctober 22, 2024
Influence of Seasonality and Public-Health Interventions on the COVID-19 Pandemic in Northern EuropeJanuary 6, 2024
Information for Clinicians on Investigational Therapeutics for Patients with COVID-19December 4, 2020
Informed consent disclosure to vaccine trial subjects of risk of COVID-19 vaccines worsening clinical diseaseDecember 4, 2020
Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trialApril 12, 2021
Inhaled CO2 Concentration While Wearing Face Masks: A Pilot Study Using CapnographySeptember 15, 2022
Injections from Hell?May 14, 2023
Innate Immune Suppression by SARS-CoV-2 mRNA Vaccinations: The role of G-quadruplexes, exosomes and microRNAsApril 15, 2022
Insights from a computational analysis of the SARS-CoV-2 Omicron variant: Host-pathogen interaction, pathogenicity and possible therapeuticsJanuary 20, 2022
Interim Operational Considerations for Implementing the Shielding Approach to Prevent COVID-19 Infections in Humanitarian SettingsJuly 26, 2020
Interim position paper: considerations regarding proof of COVID-19 vaccination for international travelersFebruary 5, 2021
Interim Report: An Analysis of the Origins of the COVID-19 PandemicOctober 2022
International Covenant on Civil and Political RightsDecember 16, 1966
Interview with Dr. Anthony FauciJuly 16, 2020
Interview with Dr. David Nabarro, WHO Special Envoy on COVID-19October 9, 2020
Interview with Dr. Ute KrügerJuly 22, 2022
Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell LineFebruary 25, 2022
Intracerebral Hemorrhage due to Thrombosis with Thrombocytopenia Syndrome after Vaccination against COVID-19: the First Fatal Case in KoreaAugust 2, 2021
Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, FranceNovember 30, 2020
Intramyocardial Inflammation after COVID-19 Vaccination: An Endomyocardial Biopsy-Proven Case SeriesJune 22, 2022